ATE238287T1 - 6-azauracilderivate als il-5 inhibitoren - Google Patents
6-azauracilderivate als il-5 inhibitorenInfo
- Publication number
- ATE238287T1 ATE238287T1 AT99963332T AT99963332T ATE238287T1 AT E238287 T1 ATE238287 T1 AT E238287T1 AT 99963332 T AT99963332 T AT 99963332T AT 99963332 T AT99963332 T AT 99963332T AT E238287 T1 ATE238287 T1 AT E238287T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- azauracil derivatives
- azauracil
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203929 | 1998-11-23 | ||
| PCT/EP1999/009154 WO2000031053A1 (en) | 1998-11-23 | 1999-11-22 | Il-5 inhibiting 6-azauracil derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE238287T1 true ATE238287T1 (de) | 2003-05-15 |
Family
ID=8234365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99963332T ATE238287T1 (de) | 1998-11-23 | 1999-11-22 | 6-azauracilderivate als il-5 inhibitoren |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6498158B1 (de) |
| EP (1) | EP1133483B1 (de) |
| JP (1) | JP2002530390A (de) |
| AR (1) | AR021362A1 (de) |
| AT (1) | ATE238287T1 (de) |
| AU (1) | AU759405B2 (de) |
| CA (1) | CA2352503C (de) |
| DE (1) | DE69907254T2 (de) |
| ES (1) | ES2198980T3 (de) |
| TR (1) | TR200101425T2 (de) |
| WO (1) | WO2000031053A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| ATE356113T1 (de) | 1997-05-14 | 2007-03-15 | Atherogenics Inc | Probucolbernsteinsäureester zur hemmung der expression von vcam-1 |
| EP2139320A4 (de) | 2007-03-26 | 2010-09-08 | Salutria Pharmaceuticals Llc | Verfahren und zusammensetzungen von probucol-derivaten für die behandlung von diabetes |
| RU2527177C2 (ru) | 2007-12-20 | 2014-08-27 | Энвиво Фармасьютикалз, Инк. | Четырехзамещенные бензолы |
| CN112441941B (zh) * | 2020-12-03 | 2022-08-02 | 浙江荣耀生物科技股份有限公司 | 一种1-(4-氨基苯基)环戊基甲腈的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
-
1999
- 1999-11-22 ES ES99963332T patent/ES2198980T3/es not_active Expired - Lifetime
- 1999-11-22 AR ARP990105941A patent/AR021362A1/es unknown
- 1999-11-22 CA CA002352503A patent/CA2352503C/en not_active Expired - Fee Related
- 1999-11-22 TR TR2001/01425T patent/TR200101425T2/xx unknown
- 1999-11-22 WO PCT/EP1999/009154 patent/WO2000031053A1/en not_active Ceased
- 1999-11-22 AU AU19677/00A patent/AU759405B2/en not_active Ceased
- 1999-11-22 DE DE69907254T patent/DE69907254T2/de not_active Expired - Fee Related
- 1999-11-22 JP JP2000583881A patent/JP2002530390A/ja not_active Withdrawn
- 1999-11-22 US US09/856,626 patent/US6498158B1/en not_active Expired - Fee Related
- 1999-11-22 EP EP99963332A patent/EP1133483B1/de not_active Expired - Lifetime
- 1999-11-22 AT AT99963332T patent/ATE238287T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200101425T2 (tr) | 2002-02-21 |
| AR021362A1 (es) | 2002-07-17 |
| ES2198980T3 (es) | 2004-02-01 |
| CA2352503A1 (en) | 2000-06-02 |
| CA2352503C (en) | 2009-04-07 |
| WO2000031053A1 (en) | 2000-06-02 |
| DE69907254T2 (de) | 2004-04-01 |
| AU1967700A (en) | 2000-06-13 |
| AU759405B2 (en) | 2003-04-17 |
| US6498158B1 (en) | 2002-12-24 |
| JP2002530390A (ja) | 2002-09-17 |
| EP1133483B1 (de) | 2003-04-23 |
| EP1133483A1 (de) | 2001-09-19 |
| DE69907254D1 (de) | 2003-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69930518D1 (de) | Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate | |
| ATE437862T1 (de) | Pyrimidin-5-onderivate als ldl-pla2 inhibitoren | |
| NO20010193D0 (no) | Tiobenzimidazol-derivater | |
| DE69725465D1 (de) | 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren | |
| ATE236136T1 (de) | Benzosulfonderivate | |
| DE69934788D1 (de) | Biozide benzylbiphenylderivative | |
| DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
| NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
| ATE259810T1 (de) | Phenyl-xanthinderivate | |
| ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
| NO20020565D0 (no) | Interleukin-5-hemmende 6-azauracilderivater | |
| DE69837922D1 (de) | Il-5 hemmende 6-azauracilderivate | |
| DE69814685D1 (de) | Indolderivate als PKC-Inhibitoren | |
| DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
| DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
| DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
| ATE233253T1 (de) | Chromanderivate | |
| TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
| DK1060183T3 (da) | 5-deoxycytidinderivater | |
| DE69907254D1 (de) | 6-azauracilderivate als il-5 inhibitoren | |
| EE9900585A (et) | 6-asauratsiili derivaadid IL-5 inhibiitoritena | |
| DK1140873T3 (da) | IL-5-inhiberende 6-azauracilderivater | |
| EP1124552A4 (de) | Chrysen-derivate als antitumormittel | |
| DE59907635D1 (de) | Pyrazolyldioxothiochromanoyl-derivate | |
| DE69923861D1 (de) | Il-5 hemmende 6-azauracilderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |